| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |